Provided by Tiger Trade Technology Pte. Ltd.

REMEGEN

80.700
-3.100-3.70%
Volume:835.50K
Turnover:68.45M
Market Cap:45.48B
PE:53.65
High:83.600
Open:82.050
Low:80.650
Close:83.800
52wk High:126.600
52wk Low:63.300
Shares:563.61M
HK Float Shares:208.58M
Volume Ratio:1.22
T/O Rate:0.40%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.504
ROE:109.10%
ROA:39.01%
PB:4.69
PE(LYR):53.65
PS:4.87

Loading ...

Movement Alert|RemeGen Intraday Decline 5.48% in Regular Trading, US-China Biotech Regulatory Escalation Continues to Pressure Innovative Pharma Sector

Market Focus
·
Jun 02

RemeGen invests RMB300.00 million in SPDB structured deposit, raising total cash-management exposure to RMB1.00 billion within two months

Bulletin Express
·
Jun 01

REMEGEN to Deploy 300 Million Yuan of Idle Capital in Wealth Management Product from SPDB

Stock News
·
Jun 01

Stock Track | RemeGen Plummets 5.38% Intraday Amid Escalating US-China Biotech Regulatory Tensions

Stock Track
·
Jun 01

Movement Alert|RemeGen Falls 5.08% in Regular Trading, US-China Biotech Regulatory Escalation Pressures Innovative Drug Sector

Market Focus
·
Jun 01

Movement Alert|RemeGen Rises 5.13% in Regular Trading, FDA Greenlights Telitacicept Phase II Trial for IgA Nephropathy in the US

Market Focus
·
May 29

Orient Securities Reduces Stake in REMEGEN, Selling 160,000 Shares at Average Price of HK$84.83

Stock News
·
May 26

REMEGEN Allocates Additional RMB 60 Million to Huatai Securities Wealth Management Product

Stock News
·
May 26

Huitianfu Fund Trims Stake in REMEGEN by 160,000 Shares at Approximately HK$84.83 Each

Deep News
·
May 24

Huatai-PineBridge Fund Reduces Stake in REMEGEN by 160,000 Shares at Average Price of HK$84.83

Stock News
·
May 22

Junshi Biosciences Gets Nod for New Indication for Toripalimab; Shares Down 4%

MT Newswires Live
·
May 22

Movement Alert|RemeGen Rises 3.55% in Regular Trading, Biotech Sector Rally and Strong Q1 Earnings Drive Rebound

Market Focus
·
May 21

RemeGen Allocates Additional RMB50.00 Million to HTSC Wealth Management Products, Raising Total Deployment to RMB538.00 Million

Bulletin Express
·
May 20

RemeGen Plans Board Transition, 20% Share Issuance Mandate, and Redirects IPO Proceeds Amid 2025 Profit Turnaround

Bulletin Express
·
May 20

REMEGEN issues supplemental disclosure after delayed reporting of seven wealth-management product purchases

Bulletin Express
·
May 19

REMEGEN Allocates Additional 35 Million Yuan to Huatai Securities Wealth Management Products

Stock News
·
May 19

RemeGen Invests in Wealth Management Products

MT Newswires Live
·
May 15

REMEGEN Allocates Idle Capital to Huatai Securities Financial Products

Stock News
·
May 15

RemeGen Allocates RMB 453.00 Million of Idle Cash to Low-to-Medium-Risk Wealth Management Products at Huatai Securities

Bulletin Express
·
May 15

RemeGen Allocates US$70.00 Million of Idle Funds to OCBC “Zeng Li” Structured Deposit

Bulletin Express
·
May 14